SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic Spectrum
-
Published:2024-07
Issue:
Volume:
Page:
-
ISSN:0149-2918
-
Container-title:Clinical Therapeutics
-
language:en
-
Short-container-title:Clinical Therapeutics
Author:
Preston Frank G.ORCID,
Anson Matthew,
Riley David R.,
Ibarburu Gema H.,
Henney Alexander,
Lip Gregory Y.H.,
Cuthbertson Daniel J.,
Alam Uazman,
Zhao Sizheng S.